Pathward’s Credit Scare Tests Its Comeback Story

Key Points

• Pathward Financial missed fiscal third-quarter earnings and revenue estimates, with net income falling sharply amid rising credit losses and nonperforming loans.
• Despite the earnings miss and past accounting restatements, all three analysts covering the stock rate it a Buy with roughly 20% upside potential.
• Management cut fiscal 2026 EPS guidance but issued stronger initial fiscal 2027 guidance, suggesting current credit issues may be temporary rather than a lasting trend.

Pathward Financial NASDAQ: CASH has had its share of serious bumps over the past 14 months, including accounting restatements, a Nasdaq listing scare, and concerns about the credit quality of loans. Its fiscal third-quarter earnings report did little to settle things down.

But still, analysts rate the company a Buy and project a strong 12-month upside.

Management is confident of a strong 2027, and aggressive buybacks help strengthen the case. The stock is up nearly 17% year to date.

For investors, it’s the numbers behind the reported results, and the potential for smoother roads ahead that make this company an interesting play.

A Behind-the-Scenes Player in Fintech

Sioux Falls, South Dakota is an unlikely address for one of the more interesting stories in American fintech, but that is where Pathward has built its business.

Once known as Meta Financial Group, Pathward became a key piece of plumbing behind tax-refund advances, prepaid debit cards, and “banking-as-a-service” partnerships that let fintechs such as Upstart NASDAQ: UPST, Stripe, Trustly, and Greenlight offer bank products without becoming a bank. This niche bank, behind the scenes and based in Sioux Falls, South Dakota, has carved a specialty in ways the public rarely sees.

Earnings Fall Short of Expectations

Its latest financials show a well-run operation confronting some turbulent waters. For its fiscal third quarter ended June 30, Pathward reported net income of $29 million, or $1.37 per diluted share, down sharply from $42.1 million, or $1.81 per share, a year earlier.

Wall Street expected $1.95 per share, so the miss of 58 cents stung. Revenue of $189.6 million also missed the $191.2 million consensus.

Behind the shortfall was a drop in net interest income for the period, not solely from operations, but still disappointing.

The company reported that net interest income fell 8% to $112.9 million, largely from an $11.6 million drop after selling a consumer-finance portfolio last October. That sale also hit the company’s net interest margin, as it slipped to 6.59% from 7.43% a year earlier.

Commercial Finance Provides Some Support

Offsetting some of that, however, interest income from commercial finance loans and leases rose $6.1 million year-over-year.

Adding to the difficulty, the provision for credit losses jumped to $28.3 million from just $9.3 million a year ago, and nonperforming loans ballooned to roughly $275 from $117.7 million three months earlier.

Management pointed to commercial loans for much of the increase, including a renewable-energy construction project tied to one developer, and a working-capital loan that CEO Brett Pharr called likely “a sophisticated fraud” on the earnings call.

Credit Problems Raise Concerns

Not everything was negative. Noninterest income rose 4% to $76.7 million, noninterest expenses fell 7% to $129.1 million, and the company kept buying back stock, repurchasing about 304,000 shares for about $28 million.

And the company has proven that its business can work. For example, full fiscal 2025 looked considerably healthier, pointing to a history that proves what is possible. Net income for that year came in at $185.9 million with diluted earnings per share (EPS) of $7.87, up 9%. Pathward’s return on average tangible equity was an impressive 38.75%.

Management’s guidance also reflected the current reality versus potential. Although fiscal 2026 EPS guidance was cut to between $7.80 and $8.20, the company simultaneously issued initial fiscal 2027 guidance of $9.50 to $10, implying that current credit issues are a speed bump, not a trend.

Analysts Remain Bullish

Despite the hiccups, the few analysts covering the stock like what they see.

The consensus rating is Buy, built from three Buy ratings and no Holds or Sells, with an average price target of $101, implying an upside of roughly 20%. The highest 12-month price target is $105 per share, while the lowest is $97.

Although still listed as a Buy, two recent target moves did go in the wrong direction. Keefe, Bruyette & Woods trimmed its target to $97 from $108 while keeping Outperform, and Piper Sandler cut its target to $105 from $107 while keeping Overweight, both the day after earnings. Yet, a number of firms jumped in on the stock.

An annual dividend of 20 cents, yielding about 0.24%, does little to change the story away from the results.

Past Accounting Problems Add to Risk

Indeed, the financial results carry a bit of extra weight these days. Pathward spent much of 2025 restating three years of financials after its audit committee found errors in how it accounted for third-party lending and derivative relationships. A delay to quarterly filings also prompted Nasdaq to warn the company about potential non-compliance.

That history is likely why the July 2026 credit surprise triggered such a fast reaction. Within weeks, shareholder-rights firms announced investigations into whether officers misled investors about loan quality.

Pathward is also not alone in chasing the fintech opportunity. The Bancorp NASDAQ: TBBK and Green Dot NASDAQ: GDOT each compete for similar banking-as-a-service relationships, though neither carry the rating that Pathward enjoys.

The Comeback Case Remains Intact

For investors, the risks here are clear. Pathward is battling a slide in credit quality at the same time it looks to recover from a slide in its trust. But management is confident, and if numbers can stabilize, the business environment could prove smooth.

A combination of aggressive buybacks, a rebuilt compliance program, and a more stabilized underwriting could prove, in the end, that analysts are right in their views.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source